MyFinsight
Home
About
Contact
biaf: the income statement
Download
Download image
Net loss
-$5,051,084
(-152.45%↓ Y/Y)
Provision for income tax
expense
$3,182
(24.35%↑ Y/Y)
Net loss before
provision for income tax...
-$5,047,902
(-152.61%↓ Y/Y)
Other Revenues
$258
Medical Director Fees
$17,274
Histology Service Fees
$255,586
Health Care Patient
Service
$1,172,948
Total other income
(expense), net
-$2,755,056
(-11183.35%↓ Y/Y)
Loss from operations
-$2,292,846
(-16.16%↓ Y/Y)
Other income
$513
(-94.70%↓ Y/Y)
Interest income
$1,088
(-51.17%↓ Y/Y)
Net revenue
$1,446,066
(-38.48%↓ Y/Y)
Change in fair value of
warrants issued
$2,747,460
Other expense
$3,839
(-73.88%↓ Y/Y)
Interest expense
$5,358
(-75.23%↓ Y/Y)
Total operating
expenses
$3,738,912
(-13.54%↓ Y/Y)
Depreciation and
amortization
$113,360
(-25.08%↓ Y/Y)
Selling, general and
administrative
$2,209,441
(-6.56%↓ Y/Y)
Clinical development
$143,311
(52.94%↑ Y/Y)
Research and development
$330,589
(20.43%↑ Y/Y)
Direct costs and
expenses
$942,211
(-34.58%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc. (BIAF)